PhD student in the Postgraduate Program in Pharmacology at the Institute of Biomedical Sciences (ICB/USP), integrating the Laboratory of Nanopharmaceuticals and Release Systems, with the project "Development and Application of Multifunctional Nanocarriers for Intraductal Release of Chemotherapeutics in the Treatment of Cancer of Mama", financed by the FAPESP agency. Master in Science (2020) with emphasis in Pharmacology from the Institute of Biomedical Sciences (ICB/USP), with the dissertation title: "Bioresponsive Systems for Sustained Drug Release Aiming at Chemoprevention of Breast Cancer", financed by the FAPESP agency. Graduated in 2017 in Biomedical Sciences (Universidade Estadual Paulista Júlio de Mesquita Filho) and completed Scientific Initiation at the Department of Morphology at UNESP with the project title: "Would the apoptotic effect of Raloxifene in prostate tumor cells (LNCaP) be mediated by GPR30/GPER1 receptors?", financed by the PIBIC - Rectory agency. Has experience in nanotechnology, LNP, pharmacology, carginogesis, breast cancer, prostate cancer and acute lymphocytic leukemia. Currently she is visiting PhD at the Karolinska Institute, Sweden. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
In this project, we propose the development and evaluation of nanoemulsions functionalized with hyaluronic acid for localized intraductal treatment of Ductal Carcinoma In Situ and other breast lesions (which increase the risk for development of invasive forms of Breast Cancer) combining efficacy, selectivity and reduction of systemic adverse effects of chemotherapy. In order to potentiali…
Breast cancer is the second most incident tumor in the world, presenting high mortality index. Nowadays, preventive actions include risk factors control, mammographic screening, preventive mastectomy and few chemopreventive pharmacological strategies associated with low adhesion of patients due to the serious adverse effects. Studies have shown that retinoids are capable of inhibiting mam…
Acute lymphoblastic leukemia (ALL) represents 1 every 4 pediatric cancer and commonly affects lymphocyte B cells. The survival rate increased to almost 70% after the approval of Chimeric Antigen Receptor (CAR) T cell therapy, however the limitations for a wide-scale production, costs and severe adverse effects hinders its application. In this project, we propose the optimization and appli…
| 1 / 1 | Ongoing scholarships in Brazil |
| 1 / 1 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID